Ticker Details
Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$214.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.45 | 2.14%
Avg Daily Range (30 D):	$0.28 | 1.85%
Avg Daily Range (90 D):	$0.35 | 2.41%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.04M
Avg Daily Volume (90 D):	.08M

Trade Size
Avg Trade Size (Sh.):	97
Avg Trade Size (Sh.) (30 D):	32
Avg Trade Size (Sh.) (90 D):	35

Institutional Trades
Total Institutional Trades:	1,274
Avg Institutional Trade:	$1.24M
Avg Institutional Trade (30 D):	$.69M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.18M
Avg Closing Trade (30 D):	$.72M
Avg Closing Trade (90 D):	$.72M
Avg Closing Volume:	33.43K

News

Jun 5, 2026 @ 9:00 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Na

Jan 26, 2026 @ 10:16 PM ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 1:00 AM Anika Therapeutics, Inc. INVESTIGATION: Kirby McIn... Source: Kirby Mcinerney Llp

Sep 25, 2025 @ 9:43 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is... Source: Bragar Eagel & Squire, P.C.

Sep 5, 2025 @ 9:00 AM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.76	$.02	$-.76
Diluted EPS	$-.76	$.02	$-.76
Revenue	$112.82M	$30.62M	$112.82M
Gross Profit	$63.81M	$19.18M	$63.81M
Net Income / Loss	$-10.88M	$.29M	$-10.88M
Operating Income / Loss	$-11.05M	$.65M	$-11.05M
Cost of Revenue	$49.01M	$11.44M	$49.01M
Net Cash Flow	$.24M	$-.44M	$.24M
PE Ratio